Serial Number | 76299853 |
Word Mark | MEDNOSTICS |
Filing Date | Monday, August 13, 2001 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Thursday, April 24, 2003 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, January 29, 2002 |
Goods and Services | Research, consulting and product development services rendered to pharmaceutical and healthcare companies in the fields of genomics, drug response and clinical development; consulting services rendered to medical device companies in the area of diagnostics |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, August 27, 2001 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Genaissance Pharmaceuticals |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New Haven, CT 06511 |
Party Name | Genaissance Pharmaceuticals |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New Haven, CT 06511 |
Event Date | Event Description |
Tuesday, December 16, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
Saturday, December 7, 2002 | EXTENSION 1 GRANTED |
Wednesday, October 16, 2002 | EXTENSION 1 FILED |
Monday, October 28, 2002 | PAPER RECEIVED |
Monday, October 21, 2002 | PAPER RECEIVED |
Tuesday, April 23, 2002 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, January 29, 2002 | PUBLISHED FOR OPPOSITION |
Wednesday, January 9, 2002 | NOTICE OF PUBLICATION |
Wednesday, November 14, 2001 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, October 31, 2001 | ASSIGNED TO EXAMINER |
Wednesday, October 10, 2001 | ASSIGNED TO EXAMINER |
Sunday, September 23, 2001 | ASSIGNED TO EXAMINER |